|
|
 |
 |
| |
 Printable version |
HIV protease inhibitors progression in Grenoble CHU |
Journal de Pharmacie Clinique. Volume 18, Number 1, 49-51, Mars 1999, 4es ATELIERS DU SNPHPU
|
 Résumé
Article gratuit
|
Author(s) : C. LAMBERT, S. LEGER, A. LEMOIGNE, P. FONTANILLE, I. MEYLAN |
Summary : For the last couple of years, since the appearance of a combinaison of antiretrovirals, HIV protease inhibitors have been an integral part of medicinal treatments of HIV infection. An evaluation of pharmaceutical dispensations of protease inhibitors, since their commercialization, has shown a spectacular progression of their level of consumption. This affluence of protease inhibitors goes hand in hand with the growing development of tritherapy. While the superiority of a molecule on the others, in terms of effectiveness, has yet to be proven, we can observe a marked difference in the consumption of various protease inhibitors. |
Keywords : dispensation, antiretrovirals, HIV protease inhibitors. |
|
